Panacea Index Logo

Command Palette

Search for a command to run...

Vitamin D Status of Very Low Birth Weight Neonates at Baseline and Follow-up after Daily Intake of 800 IU Vitamin D.

Journal of tropical pediatrics
January 1, 1970
Khurshed Alam Choudhury et al. (6 authors)
Journal ArticleObservational StudyHuman StudyClinical
Extracted Claims (6)
InterventionDirectionEndpointPopulationDosageImpactClaim #
daily intake of 800 IU vitamin D
decrease
prevalence of vitamin D deficiency
very low birth weight neonates less than 32 weeks
by >90%
decreased
#1
daily intake of 800 IU vitamin D
no change
vitamin D toxicity
very low birth weight neonates less than 32 weeks
-
no neonates developed
#2
-
increase
weight gain
vitamin D sufficient neonates
6.70 ± 2.40 to 8.96 ± 2.21 g/day
were more
#3
-
increase
length increments
vitamin D sufficient neonates
0.82 ± 0.34 to 1.08 ± 0.37 cm/week
were more
#4
-
increase
head circumference gain
vitamin D sufficient neonates
0.58 ± 0.09 cm/week
was
#5
-
increase
head circumference gain
vitamin D deficient neonates
0.54 ± 0.06 cm/week
was
#6
Abstract

INTRODUCTION: Vitamin D deficiency (VDD) is rampant in neonates. Recommendations for supplementation are variable. METHODS: An observational study was done on less than 32 weeks of very low birth weight neonates to find prevalence of VDD (<20 ng/ml) at baseline; at 38 ± 2 weeks post-menstrual age (PMA) after daily intake of 800 IU vitamin D (vit D). Secondary objectives were to find determinants of VDD, to compare growth in deficient; vit D sufficient (VDS) neonates; to find vit D toxicity. RESULTS: Of 83 neonates, 81 (97.6%) were VDD at baseline and 5 (6%) at 38 ± 2 weeks PMA. Determinants for VDD at baseline were inadequate maternal sun exposure (p < 0.001) and vit D supplementation (p = 0.007). Factors for VDD at 38 ± 2 weeks PMA were male gender (p = 0.049), morbidities (p = 0.006), ventilation >24 h (<0.001), sepsis (p = 0.032), caffeine (p ≤ 0.001) and missed supplements (p < 0.001). Weight and length gain of VDD to VDS neonates were (6.70 ± 2.40 to 8.96 ± 2.21 g/day); (0.82 ± 0.34 to 1.08 ± 0.37 cm/week), respectively (p < 0.001). Head circumference gain (cm/week) of VDS; VDD neonates was 0.58 ± 0.09; 0.54 ± 0.06 (p = 0.054), respectively. No neonates developed vit D toxicity. CONCLUSIONS: In preterm VLBW neonates, the prevalence of VDD was 97.6% but decreased by >90% at 38 ± 2 weeks with a daily intake of 800 IU vit D. Inadequate maternal vit D intake and sun exposure determined low baseline vit D status of neonates. Male gender, morbidities, ventilation, sepsis, caffeine, missed vitamin D supplements were determinants of poor vit D status at follow-up. Weight gain and length increments were more in the VDS group.

Medical Subject Headings (MeSH)
FemaleFollow-Up StudiesHumansInfant, NewbornInfant, Very Low Birth WeightMaleVitamin DVitamin D DeficiencyVitamins
Study Links
Citation Metrics
Total Citations2
Citations/Year0.5
Relative Citation Ratio0.29
NIH Percentile15%
Research Impact Scores
APT Score0.50
Related Supplements